Roivant Sciences (ROIV) Retained Earnings (2021 - 2026)

Roivant Sciences has reported Retained Earnings for 6 years, with the latest figure at -$501.8 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 532.37% year-over-year to -$501.8 million; the trailing twelve-month figure through Mar 2026 stood at -$501.8 million (down 532.37% YoY), and the FY2026 full-year result was -$501.8 million, down 532.37% from the prior year.
• Retained Earnings for Q1 2026 stood at -$501.8 million, down from $20.6 million in the prior quarter.
• The five-year high for Retained Earnings was $727.3 million in Q4 2023, with the low at -$4.4 billion in Q3 2023.
• Historically, Retained Earnings has averaged -$816.8 million across 5 years, with a median of -$946000.0 in 2022.
• Annual changes were most pronounced in 2022 — Retained Earnings sank 349352.06% — and 2024, when it surged 22116.51%.
• Roivant Sciences' Retained Earnings stood at -$3.7 billion in 2022, then soared by 119.45% to $727.3 million in 2023, then slumped by 36.7% to $460.4 million in 2024, then tumbled by 95.52% to $20.6 million in 2025, then slumped by 2534.81% to -$501.8 million in 2026.
• The last three Retained Earnings figures came in at -$501.8 million (Q1 2026), $20.6 million (Q4 2025), and -$429.1 million (Q3 2025), per Business Quant data.